[Streptozotocin].
D007516:Adenoma, Islet Cell / Q000188:drug therapy; D000818:Animals; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000139:chemically induced; D004352:Drug Resistance, Microbial; D006801:Humans; D066298:In Vitro Techniques; D007515:Islets of Langerhans / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D009243:NAD / Q000378:metabolism; D009539:Nicotinic Acids / Q000494:pharmacology; D009603:Nitroso Compounds; D010179:Pancreas / Q000187:drug effects; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D051381:Rats; D013311:Streptozocin / Q000009:adverse effects / Q000032:analysis / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D014508:Urea
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D009539:Nicotinic Acids; D009603:Nitroso Compounds; D009243:NAD; D013311:Streptozocin; D014508:Urea
Streptozotocin.